Garlic
Also sold as: Allium sativum · Allicin · Aged garlic extract · S-allylcysteine
Garlic preparations are studied for blood pressure and lipid/glucose markers. Aged garlic extract contains stable sulfur compounds such as S-allylcysteine and differs from allicin-generating raw garlic.
Longevity
Community
Not enough ratings yet: 0 of 10
Scores appear after 10 ratings, so that one or two reports can't dominate. Tried it? Your rating counts.
Research
- Longevity: General lifespan extension is unestablished; blood pressure, lipid and plaque changes are surrogate outcomes.
REALITY CHECK // Garlic can lower blood pressure over weeks, especially in hypertension, but prevention of heart attacks or longer life has not been demonstrated. Enteric coating is not automatically better absorption, and aged extract can have clinical effects without containing allicin. Cancer associations and a single weak cold trial do not justify broad prevention claims.
Levels: how we grade evidence. Grey = evidence of no benefit; amber = evidence it makes this goal worse.
Ratings are self-reported by a self-selected group of users: how it felt, not proof that it works.
Check your bottle
Compare what your label says with what was used in trials. This is a trial range, not a personal prescription.
Enter the amount from your label to see the result.
How it was studied
01 // STUDIED_DOSE_RANGE
Trial exposure, not a prescription
Trials used about 600-1,200 mg/day garlic powder, usually for at least 8-12 weeks. A plaque-imaging trial used 2,400 mg/day aged garlic extract for 12 months. The cold trial reported a 180 mg/day allicin-containing supplement, with active-allicin attribution requiring review.
02 // TIMING_&_MATRIX
Preparation matters
Crushing activates alliinase; the dossier describes waiting about 10 minutes. High-protein meals can reduce enteric-tablet allicin delivery; fasting raw garlic can worsen GI symptoms.
03 // EVALUATION_WINDOW
Measure the relevant outcome
Assess blood-pressure/lipid interventions over 8-12 weeks; the aged-extract imaging trial lasted 12 months and still measured a surrogate.
04 // SAFETY_&_QUALITY_GATE
Check medicines and the label
Distinguish powder, aged extract and allicin units; review bleeding, surgery, HIV therapy and diabetes medicines.
UPPER LIMIT // No established EFSA or NIH upper intake level for garlic/allicin is supplied. Powder and aged-extract trial doses are not safety ceilings or equivalent active-compound exposures.
Summary
Blood-pressure lowering is the clearest clinical signal, particularly with baseline hypertension. Lipid and glucose effects are modest and heterogeneous; small aged-extract plaque studies do not establish fewer cardiovascular events. Cancer-prevention and cold claims are much less convincing than marketing suggests.
Mechanism
Crushing allows alliinase to convert alliin to allicin. Aged extracts contain stable water-soluble compounds such as S-allylcysteine rather than allicin; sulfur-related vascular mechanisms do not make all preparations interchangeable.
Typical studied dose
Trials used about 600-1,200 mg/day garlic powder, usually for at least 8-12 weeks. A plaque-imaging trial used 2,400 mg/day aged garlic extract for 12 months. The cold trial reported a 180 mg/day allicin-containing supplement, with active-allicin attribution requiring review.
Upper limit
No established EFSA or NIH upper intake level for garlic/allicin is supplied. Powder and aged-extract trial doses are not safety ceilings or equivalent active-compound exposures.
Popular stacks with Garlic
Not enough stack data yet. A combination with Garlic appears here once 5 people rate the same set.
Forms and label traps
| Form on label | Active content | Studied range / day | Absorption & GI tolerance | Verdict |
|---|---|---|---|---|
| Crushed raw garlic Best for: Culinary use if tolerated. |
Unstandardized: active content unknown | no comparable trial range | Used as a reference in breath-AMS allicin bioavailability testing; not a 100% clinical-efficacy conversion. Burning, reflux and odor; often worse fasting. |
Caution CAUTION The dossier estimates roughly 5-9 mg allicin per clove after crushing and waiting about 10 minutes; clove mass and chemistry vary, so no validated mg conversion is supplied. |
| Garlic powder / enteric tablets Best for: Matching powder-based blood-pressure studies. |
Extract weight · marker not quantified | 600–1200 mg | Enteric allicin bioavailability varied 36-104%, falling to 22-57% with high-protein meals; non-enteric tablets ranged 80-111% in the cited assay. Often less burning and odor than raw garlic. |
Good option GOOD Compare full powder mass; allicin release potential is a separate, formulation-dependent label claim. |
| Aged garlic extract Best for: Matching the aged-extract plaque-imaging trial. |
Extract weight · marker not quantified | 2400–2400 mg | S-allylcysteine is stable and well absorbed; aged extract has a different sulfur profile from raw garlic. Generally the best-tolerated, low-odor option in the dossier. |
Studied standard REFERENCE 2,400 mg refers to extract, not allicin or pure S-allylcysteine; marker content is not supplied. |
| Allicin-standardized products Best for: Only products disclosing actual release data. |
Unstandardized: active content unknown | no comparable trial range | Delivery depends on formulation and release conditions. Variable GI tolerance. |
Caution CAUTION Numbers such as 5000 may mean micrograms of potential allicin rather than milligrams delivered; no universal active percentage can be assumed. |
Common label traps
- TRAP_01 // Garlic prevents cancer
Observational associations weaken in prospective data; the large randomized trial did not significantly lower gastric-cancer incidence. - TRAP_02 // 5000 means 5,000 mg active allicin
Label numbers can refer to micrograms or release potential. Extract, powder and allicin quantities need separate units. - TRAP_03 // Enteric coating guarantees absorption
Allicin delivery varied widely and fell with high-protein meals in the bioavailability study. - TRAP_04 // Odorless aged garlic is inactive
Aged extract contains S-allylcysteine, not allicin, and was used in vascular trials.
Other outcomes studied
Outside the five leaderboard goals. Same evidence levels as above.
- BLOOD_PRESSURE Moderate · benefit
RCT syntheses favor lower blood pressure after at least 8-12 weeks, especially in hypertension. The 20-trial synthesis reported SBP -5.1 and DBP -2.5 mmHg overall; hypertensive subgroups had larger reductions.
PMID 26764326 PMID 25837272 PMID 18554422 PMID 39437887 PMID 40580481 - LIPIDS Moderate · benefit
Older 29-RCT analysis found TC -0.19 mmol/L and triglycerides -0.11 mmol/L, with no clear LDL/HDL effect. The 2024 analysis found TC -14.17 and LDL -8.20 mg/dL, HDL +2.06 mg/dL, but no significant triglyceride effect. Product and baseline status matter.
PMID 19555517 PMID 38892625 PMID 19250134 PMID 35988871 - GLUCOSE_CONTROL Moderate · benefit
RCT meta-analyses favor fasting glucose lowering. The 2024 synthesis reported -7.01 mg/dL fasting glucose and -0.66 percentage points HbA1c, with substantial HbA1c heterogeneity; adjunctive evidence, not replacement therapy.
PMID 26693740 PMID 38892625 PMID 30049636 - CORONARY_PLAQUE Limited · benefit
Small aged-extract imaging trials suggest slower calcification or lower low-attenuation plaque. In 66 patients with diabetes, 2,400 mg/day for 12 months changed normalized low-attenuation plaque, not total/fibrous plaque. Some trials used combinations; no event reduction is established.
PMID 32010322 PMID 16484554 PMID 26764322 PMID 23453866 PMID 29140808 - COMMON_COLD Limited · benefit
One manufacturer-linked, self-reported trial in 146 adults reported 24 versus 65 colds over 12 weeks. Cochrane found only one eligible study and insufficient evidence for reliable prevention claims.
PMID 11697022 PMID 25386977 PMID 22419312 - CANCER_PREVENTION Limited · no benefit
Observational associations do not establish causality. In the randomized Linqu follow-up, gastric-cancer incidence was not significantly lower (OR 0.81, 95% CI 0.57-1.13); mortality was borderline (HR 0.66, 95% CI 0.43-1.00). This is not proof of general cancer prevention.
PMID 11010950 PMID 30155945 PMID 31511230 PMID 25339056 - H_PYLORI Limited · no benefit
A review reported 10 of 13 studies without a significant infection effect. pH-dependent inhibition is in vitro and does not establish clinical eradication.
PMID 30155945 PMID 37511809 PMID 11238826
Reader questions
Does aged garlic still work without allicin?
Its chemistry is different: stable S-allylcysteine replaces allicin as a key marker. Use evidence for the specific aged preparation, especially plaque studies, rather than transferring every raw-garlic claim.
How can I reduce burning or odor?
Raw garlic is the least GI-friendly form. Aged extract is generally better tolerated, but a preparation change also changes the evidence and dose basis; persistent burning is a reason to stop.
Can I take extra capsules for high blood pressure?
The powder trials used roughly 600-1,200 mg/day, while a plaque trial used 2,400 mg/day aged extract. These are different products, not a dosing ladder. Discuss hypertension management and interactions with a clinician.
Does garlic prevent cancer or colds?
Cancer epidemiology is not a capsule efficacy trial. The cold evidence rests heavily on one weak study, and randomized gastric-cancer incidence was not significantly reduced.
Stack interactions
- Caution Warfarin / antiplatelet drugs / surgery [CAUTION]
Mechanism and perioperative case reports support caution, but a controlled trial found no significant garlic-warfarin PK/PD interaction in healthy subjects. Have the surgical or prescribing team set management.
PMID 18516070 PMID 27782907 PMID 27751305 PMID 11144706 PMID 24790635 - Caution Saquinavir / HIV protease inhibitors [CAUTION]
A clinical report describes about 50% lower saquinavir levels; additional transport/metabolism studies are preclinical. Avoid unsupervised combination because antiviral efficacy may be compromised.
PMID 11810949 PMID 20930421 PMID 21104925 PMID 20610890 - Caution Diabetes medicines [CAUTION]
Glucose-lowering effects may add to medication; monitor glucose with the treating team.
PMID 26693740 PMID 38892625 - Caution High-protein meals with enteric tablets [CAUTION]
Meal composition reduced allicin bioavailability in the formulation study; this is not proof that all garlic should be taken fasting.
PMID 29937536
Red flags: interactions and who should avoid it
Interactions
Potential additive bleeding risk with antiplatelet/anticoagulant agents and other antiplatelet supplements; a controlled healthy-volunteer trial did not find a significant garlic-warfarin PK/PD interaction. Garlic supplements reduced saquinavir exposure by about 50% in the dossier report. Glucose lowering can add to diabetes treatment; high-protein meals alter enteric-tablet allicin delivery.
Avoid or ask a doctor first if
Avoid unsupervised supplements with HIV protease inhibitors or anticoagulation; review before surgery and arrange an appropriate stop interval with the surgical team (the dossier cites 7-10 days). Concentrated doses lack adequate pregnancy/lactation data. Raw garlic can worsen reflux, ulcer symptoms and burning; rash and intolerance can occur.
Sources (PubMed, 37)
- Garlic Lowers Blood Pressure in Hypertensive Individuals, Regulates Serum Cholesterol, and Stimulates Immunity: An Updated Meta-analysis and Review.
PMID 26764326 · 2016 · systematic review / meta-analysisRCT syntheses favor lower blood pressure after at least 8-12 weeks, especially in hypertension. The 20-trial synthesis reported SBP -5.1 and DBP -2.5 mmHg overall; hypertensive subgroups had larger reductions.
- Garlic for hypertension: A systematic review and meta-analysis of randomized controlled trials.
PMID 25837272 · 2015 · systematic review / meta-analysisRCT syntheses favor lower blood pressure after at least 8-12 weeks, especially in hypertension. The 20-trial synthesis reported SBP -5.1 and DBP -2.5 mmHg overall; hypertensive subgroups had larger reductions.
- Effect of garlic on blood pressure: a systematic review and meta-analysis.
PMID 18554422 · 2008 · systematic review / meta-analysisRCT syntheses favor lower blood pressure after at least 8-12 weeks, especially in hypertension. The 20-trial synthesis reported SBP -5.1 and DBP -2.5 mmHg overall; hypertensive subgroups had larger reductions.
- Effects of aged garlic extract on blood pressure in hypertensive patients: A systematic review and meta-analysis of randomized controlled trials.
PMID 39437887 · 2024 · systematic review / meta-analysisRCT syntheses favor lower blood pressure after at least 8-12 weeks, especially in hypertension. The 20-trial synthesis reported SBP -5.1 and DBP -2.5 mmHg overall; hypertensive subgroups had larger reductions.
- Effects of Garlic Supplementation on Cardiovascular Risk Factors in Adults: A Comprehensive Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
PMID 40580481 · 2026 · systematic review / meta-analysisRCT syntheses favor lower blood pressure after at least 8-12 weeks, especially in hypertension. The 20-trial synthesis reported SBP -5.1 and DBP -2.5 mmHg overall; hypertensive subgroups had larger reductions.
- The impact of garlic on lipid parameters: a systematic review and meta-analysis.
PMID 19555517 · 2009 · systematic review / meta-analysisOlder 29-RCT analysis found TC -0.19 mmol/L and triglycerides -0.11 mmol/L, with no clear LDL/HDL effect. The 2024 analysis found TC -14.17 and LDL -8.20 mg/dL, HDL +2.06 mg/dL, but no significant triglyceride effect. Product and baseline status matter.
- Effects of Garlic on Glucose Parameters and Lipid Profile: A Systematic Review and Meta-Analysis on Randomized Controlled Trials.
PMID 38892625 · 2024 · systematic review / meta-analysisOlder 29-RCT analysis found TC -0.19 mmol/L and triglycerides -0.11 mmol/L, with no clear LDL/HDL effect. The 2024 analysis found TC -14.17 and LDL -8.20 mg/dL, HDL +2.06 mg/dL, but no significant triglyceride effect. Product and baseline status matter.
- Garlic supplementation and serum cholesterol: a meta-analysis.
PMID 19250134 · 2009 · systematic review / meta-analysisOlder 29-RCT analysis found TC -0.19 mmol/L and triglycerides -0.11 mmol/L, with no clear LDL/HDL effect. The 2024 analysis found TC -14.17 and LDL -8.20 mg/dL, HDL +2.06 mg/dL, but no significant triglyceride effect. Product and baseline status matter.
- A network meta-analysis on the comparative effect of nutraceuticals on lipid profile in adults.
PMID 35988871 · 2022 · systematic review / meta-analysisOlder 29-RCT analysis found TC -0.19 mmol/L and triglycerides -0.11 mmol/L, with no clear LDL/HDL effect. The 2024 analysis found TC -14.17 and LDL -8.20 mg/dL, HDL +2.06 mg/dL, but no significant triglyceride effect. Product and baseline status matter.
- Garlic intake lowers fasting blood glucose: meta-analysis of randomized controlled trials.
PMID 26693740 · 2015 · systematic review / meta-analysisRCT meta-analyses favor fasting glucose lowering. The 2024 synthesis reported -7.01 mg/dL fasting glucose and -0.66 percentage points HbA1c, with substantial HbA1c heterogeneity; adjunctive evidence, not replacement therapy.
- The effect of garlic on lipid profile and glucose parameters in diabetic patients: A systematic review and meta-analysis.
PMID 30049636 · 2019 · systematic review / meta-analysisRCT meta-analyses favor fasting glucose lowering. The 2024 synthesis reported -7.01 mg/dL fasting glucose and -0.66 percentage points HbA1c, with substantial HbA1c heterogeneity; adjunctive evidence, not replacement therapy.
- Aged garlic extract reduces low attenuation plaque in coronary arteries of patients with diabetes: A randomized, double-blind, placebo-controlled study.
PMID 32010322 · 2020 · randomized controlled trialSmall aged-extract imaging trials suggest slower calcification or lower low-attenuation plaque. In 66 patients with diabetes, 2,400 mg/day for 12 months changed normalized low-attenuation plaque, not total/fibrous plaque. Some trials used combinations; no event reduction is established.
- Aged garlic extract retards progression of coronary artery calcification.
PMID 16484554 · 2006 · randomized controlled trialSmall aged-extract imaging trials suggest slower calcification or lower low-attenuation plaque. In 66 patients with diabetes, 2,400 mg/day for 12 months changed normalized low-attenuation plaque, not total/fibrous plaque. Some trials used combinations; no event reduction is established.
- Aged Garlic Extract Reduces Low Attenuation Plaque in Coronary Arteries of Patients with Metabolic Syndrome in a Prospective Randomized Double-Blind Study.
PMID 26764322 · 2016 · randomized controlled trialSmall aged-extract imaging trials suggest slower calcification or lower low-attenuation plaque. In 66 patients with diabetes, 2,400 mg/day for 12 months changed normalized low-attenuation plaque, not total/fibrous plaque. Some trials used combinations; no event reduction is established.
- Aged garlic extract with supplement is associated with increase in brown adipose, decrease in white adipose tissue and predict lack of progression in coronary atherosclerosis.
PMID 23453866 · 2013 · randomized controlled trialSmall aged-extract imaging trials suggest slower calcification or lower low-attenuation plaque. In 66 patients with diabetes, 2,400 mg/day for 12 months changed normalized low-attenuation plaque, not total/fibrous plaque. Some trials used combinations; no event reduction is established.
- Randomized trial evaluating the effect of aged garlic extract with supplements versus placebo on adipose tissue surrogates for coronary atherosclerosis progression.
PMID 29140808 · 2018 · randomized controlled trialSmall aged-extract imaging trials suggest slower calcification or lower low-attenuation plaque. In 66 patients with diabetes, 2,400 mg/day for 12 months changed normalized low-attenuation plaque, not total/fibrous plaque. Some trials used combinations; no event reduction is established.
- Preventing the common cold with a garlic supplement: a double-blind, placebo-controlled survey.
PMID 11697022 · 2001 · randomized controlled trialOne manufacturer-linked, self-reported trial in 146 adults reported 24 versus 65 colds over 12 weeks. Cochrane found only one eligible study and insufficient evidence for reliable prevention claims.
- Garlic for the common cold.
PMID 25386977 · 2014 · systematic review / meta-analysisOne manufacturer-linked, self-reported trial in 146 adults reported 24 versus 65 colds over 12 weeks. Cochrane found only one eligible study and insufficient evidence for reliable prevention claims.
- Garlic for the common cold.
PMID 22419312 · 2012 · systematic review / meta-analysisOne manufacturer-linked, self-reported trial in 146 adults reported 24 versus 65 colds over 12 weeks. Cochrane found only one eligible study and insufficient evidence for reliable prevention claims.
- Garlic consumption and cancer prevention: meta-analyses of colorectal and stomach cancers.
PMID 11010950 · 2000 · systematic review / meta-analysisObservational associations do not establish causality. In the randomized Linqu follow-up, gastric-cancer incidence was not significantly lower (OR 0.81, 95% CI 0.57-1.13); mortality was borderline (HR 0.66, 95% CI 0.43-1.00). This is not proof of general cancer prevention.
- The association of garlic with Helicobacter pylori infection and gastric cancer risk: A systematic review and meta-analysis.
PMID 30155945 · 2018 · systematic review / meta-analysisObservational associations do not establish causality. In the randomized Linqu follow-up, gastric-cancer incidence was not significantly lower (OR 0.81, 95% CI 0.57-1.13); mortality was borderline (HR 0.66, 95% CI 0.43-1.00). This is not proof of general cancer prevention.
- Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial.
PMID 31511230 · 2019 · randomized controlled trialObservational associations do not establish causality. In the randomized Linqu follow-up, gastric-cancer incidence was not significantly lower (OR 0.81, 95% CI 0.57-1.13); mortality was borderline (HR 0.66, 95% CI 0.43-1.00). This is not proof of general cancer prevention.
- Diet and cancer risk in the Korean population: a meta- analysis.
PMID 25339056 · 2014 · systematic review / meta-analysisObservational associations do not establish causality. In the randomized Linqu follow-up, gastric-cancer incidence was not significantly lower (OR 0.81, 95% CI 0.57-1.13); mortality was borderline (HR 0.66, 95% CI 0.43-1.00). This is not proof of general cancer prevention.
- Garlic Extracts: Effect of pH on Inhibition of Helicobacter pylori.
PMID 37511809 · 2023 · in vitro studyA review reported 10 of 13 studies without a significant infection effect. pH-dependent inhibition is in vitro and does not establish clinical eradication.
- Protection against Helicobacter pylori and other bacterial infections by garlic.
PMID 11238826 · 2001 · in vitro studyA review reported 10 of 13 studies without a significant infection effect. pH-dependent inhibition is in vitro and does not establish clinical eradication.
- Allicin Bioavailability and Bioequivalence from Garlic Supplements and Garlic Foods.
PMID 29937536 · 2018 · randomized controlled trialMeal composition reduced allicin bioavailability in the formulation study; this is not proof that all garlic should be taken fasting.
- Composition, stability, and bioavailability of garlic products used in a clinical trial.
PMID 16076102 · 2005 · other research reportUsed as a reference in breath-AMS allicin bioavailability testing; not a 100% clinical-efficacy conversion. The dossier estimates roughly 5-9 mg allicin per clove after crushing and waiting about 10 minutes; clove mass and chemistry vary, so no validated mg conversion is supplied.
- Bioavailability, Health Benefits, and Delivery Systems of Allicin: A Review.
PMID 37943254 · 2023 · narrative reviewDelivery depends on formulation and release conditions. Numbers such as 5000 may mean micrograms of potential allicin rather than milligrams delivered; no universal active percentage can be assumed.
- Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects.
PMID 18516070 · 2008 · randomized controlled trialMechanism and perioperative case reports support caution, but a controlled trial found no significant garlic-warfarin PK/PD interaction in healthy subjects. Have the surgical or prescribing team set management.
- Garlic-Induced Surgical Bleeding: How Much Is Too Much?
PMID 27782907 · 2016 · other research reportMechanism and perioperative case reports support caution, but a controlled trial found no significant garlic-warfarin PK/PD interaction in healthy subjects. Have the surgical or prescribing team set management.
- Bleeding risk of dietary supplements: A hidden nightmare for cardiac surgeons.
PMID 27751305 · 2016 · other research reportMechanism and perioperative case reports support caution, but a controlled trial found no significant garlic-warfarin PK/PD interaction in healthy subjects. Have the surgical or prescribing team set management.
- Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: nature of the evidence.
PMID 11144706 · 2000 · narrative reviewMechanism and perioperative case reports support caution, but a controlled trial found no significant garlic-warfarin PK/PD interaction in healthy subjects. Have the surgical or prescribing team set management.
- Updates on the clinical evidenced herb-warfarin interactions.
PMID 24790635 · 2014 · narrative reviewMechanism and perioperative case reports support caution, but a controlled trial found no significant garlic-warfarin PK/PD interaction in healthy subjects. Have the surgical or prescribing team set management.
- Garlic reduces saquinavir blood levels 50%; may affect other drugs.
PMID 11810949 · 2001 · research report; design requires reviewA clinical report describes about 50% lower saquinavir levels; additional transport/metabolism studies are preclinical. Avoid unsupervised combination because antiviral efficacy may be compromised.
- Garlic flavonoids and organosulfur compounds: impact on the hepatic pharmacokinetics of saquinavir and darunavir.
PMID 20930421 · 2010 · in vitro studyA clinical report describes about 50% lower saquinavir levels; additional transport/metabolism studies are preclinical. Avoid unsupervised combination because antiviral efficacy may be compromised.
- HIV protease inhibitors: garlic supplements and first-pass intestinal metabolism impact on the therapeutic efficacy.
PMID 21104925 · 2010 · in vitro studyA clinical report describes about 50% lower saquinavir levels; additional transport/metabolism studies are preclinical. Avoid unsupervised combination because antiviral efficacy may be compromised.
- The influence of aged garlic extract on the uptake of saquinavir and darunavir into HepG2 cells and rat liver slices.
PMID 20610890 · 2010 · in vitro studyA clinical report describes about 50% lower saquinavir levels; additional transport/metabolism studies are preclinical. Avoid unsupervised combination because antiviral efficacy may be compromised.
Community comments
No approved comments yet. Comments are held for moderation.